Tech Company Financing Transactions
Potentia Pharmaceuticals Funding Round
MASA Life Science Ventures participated in a $5 million Series A venture round for Potentia Pharmaceuticals. The round was announced on 3/6/2007.
Transaction Overview
Company Name
Announced On
3/6/2007
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
MASA Life Science Ventures (Sinclair Dunlop)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
201 E. Jefferson Street 312
Louisville, KY 40202
USA
Louisville, KY 40202
USA
Phone
Website
Email Address
Overview
Potentia Pharmaceuticals, Inc. is an early stage biotechnology company focused on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases, with an initial emphasis on diseases of the eye such as age-related macular degeneration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cedric Francois
Chief Medical Officer
Jason Slakter
Chief Operating Officer
Pascal Deschatelets
Chief Scientific Officer
Paul Olson
VP - General Counsel
Monica Gerber
Browse more venture capital transactions:
Prev: 3/6/2007: TicketsNow venture capital transaction
Next: 3/6/2007: MedPageToday venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs